News
Yet core facility operators contend they have a role to play in the biotech market, saying that their higher prices are offset by better service and quality control. Today's DNA synthesizers are ...
IDT and Elegen partner to launch an early access program offering long, clonal gene synthesis and high-complexity genes up to ...
Biopharmaceuticals represent another significant market segment, holding a dominant share of 44.2%. The increasing emphasis on biologics, gene therapies, and personalized medicine is fueling the ...
(Image: National Human Genome Research Institute) (click on image to enlarge) Developed by Frederick Sanger in the 1970s, Sanger sequencing was the first widely used method for DNA sequencing. This ...
The nucleosides are rich in exposed hydroxyl and amino groups, so scientists use protecting groups to prevent unintended reactions with compounds used in DNA synthesis. Chemicals remove the protecting ...
5d
News-Medical.Net on MSNSweetener saccharin revives old antibiotics by breaking bacterial defencesSaccharin destabilizes bacterial membranes and interferes with DNA replication, causing lysis and impairing virulence traits.
11d
Zacks Investment Research on MSNPromising Genomics & Synthetic Biology Stocks to Consider in 2025Genomics encompasses the study of a complete set of genes, their work process, and their way of interacting with each other and the environment. While it incorporates elements of genetics, the primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results